10 Top Antidepressants Market to Watch | Fortune Business Insights™

Share on facebook
Share on twitter
Share on linkedin

The global antidepressants market size is projected to reach USD 18.29 billion by 2027, exhibiting a CAGR of 2.9% during the forecast period. The skyrocketing demand for depression management drugs amid the COVID-19 pandemic will rapidly broaden the horizons of this market, observes Fortune Business Insights™ in its report, titled “Antidepressants Market Size, Share & Industry Analysis, By Drug Class (Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), Atypical Antidepressants, Tricyclic Antidepressants (TCAs), and Atypical Antipsychotics), Monoamine Oxidase Inhibitors (MAOIs), and Others), By Disorder (Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Generalized Anxiety Disorder, Panic Disorder, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027”. According to a joint study conducted by researchers from Boston University, Brown University, and the Hassenfeld Child Health Innovation Institute, depression symptoms were three times higher during the coronavirus-induced lockdown.

Request a Sample Copy of the Research Report


List of Key Companies Covered in the Antidepressants Market Report:

  • Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel)
  • AstraZeneca (Cambridge, U.K)
  • Pfizer Inc. (New York, U.S)
  • Eli Lilly and Company (Indiana, U.S)
  • Lundbeck A/S (Denmark, Europe)
  • Bristol-Myers Squibb (New York, U.S)
  • Merck & Co. Inc. (New Jersey, U.S)
  • Janssen Pharmaceuticals (Beerse, Belgium)
  • GlaxoSmithKline plc (Brentford, U.K)

The sudden spike in the prevalence of anxiety and depressive tendencies among populations has created major shortages of essential antidepressants worldwide. In Canada, for instance, Pfizer’s anti-depressant, Nardil, went out of stock in June 2020 and Health Canada predicts that the drug shortage is likely to last till August 2021. Furthermore, the US Food and Drug Administration (FDA) revealed in June 2020 that the antidepressant Zoloft is facing huge shortages as the pandemic has disrupted pharmaceutical supply chains. The dramatic rise in the demand for depression medications and the consequent surge in sales enabled the market to showcase a prolific CAGR of 28.0% in 2020, reaching USD 14.93 billion in value.

The report states that the global market value stood at USD 11.67 billion in 2019 and features the following highlights:

  • Elaborative overview of the industry outlook and trends;
  • Valuable insights into the market drivers, opportunities, and restraints;
  • Unmatched analysis of the regional dynamics and competitive milieu shaping the market; and
  • Holistic & piecemeal study of each individual segment of the market.

Driving Factor

Increasing Application of AI in Detecting Depression to Open Floodgates of Innovation

The employment of artificial intelligence (AI) in identifying depressive behaviors in individuals is paving new pathways for the antidepressants market growth. Several startups, healthcare technology entities, and academic institutions have been AI-based algorithms, systems, and tools for depression. For example, Baltimore-based Sunrise Health, a startup incubated under Johns Hopkins Technology Ventures, has developed a system that uses AI-based predictive analytics to regulate patient activity and inhibit the onset of mental health breakdown episodes through support-group texting. On the other hand, California-based startup, Mindstrong Health, utilizes machine learning (ML) to aid the diagnosis and treatment of behavioral health disorders by leveraging data generated from smartphones. In June 2020, psychiatry researchers at Stanford University developed an AI-based algorithm to study brainwave patterns specific to depression patients, aiming to identify which symptoms change with treatment in a more pinpointed manner. Thus, AI has displayed vast potential in enhancing the efficacy and accuracy of antidepressants, thereby brightening the outlook of this market.

Quick Buy


Regional Insights

Presence of Leading Market Players to Catalyze the Market in North America

North America is expected to dominate the antidepressants market share during the forecast period, backed by the strong presence and widespread operations of large pharmaceutical companies, such as Pfizer and Merck, in the US. These conglomerates, due to their sound financial health, are constantly engaged in the creation and launch of novel depression therapies, which has been the primary factor for the region’s apex position in this market. The North America market size stood at USD 6.00 billion in 2019.

In Europe, rising investments in clinical trials and huge funding for research & development activities will foster lasting growth of the regional market. On the other hand, Asia Pacific is set to present lucrative opportunities over the next decade as the increasing incidence of depression and anxiety disorders will stoke the adoption of antidepressants.

Competitive Landscape

Mergers & Collaborations to be the Principal Growth Strategies for Key Players

The prominent players in this market are rapidly adopting the strategies of mergers and collaborations to expand their market footprint. These strategies are allowing companies to mutually benefit from each other’s portfolios, technologies, and research related to antidepressants.

Industry Developments:

  • December 2020: NeuroRx and Big Rock Partners Acquisition inked a merger agreement worth USD 500 million. The merger will strengthen NeuroRx’s clinical-stage development of treatments for bipolar depression and COVID-19.
  • June 2020: Neurocrine Biosciences and Takeda Pharmaceutical entered into a strategic partnership to develop and commercialize Takeda’s psychiatry pipeline candidates. Under the agreement, Neurocrine will grant an exclusive license to Takeda for three clinical-stage assets for schizophrenia, treatment-resistant depression, and anhedonia.

Have Any Query? Ask Our Experts


Table Of Content

  • Introduction
    • Market Scope
    • Market Segmentation
    • Market Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Anxiety & Depression –Key Regions/Country
    • New Product Launch
    • Pipeline Analysis
    • Impact of COVID-19 on the Antidepressants Market
    • Key Industry Developments – Mergers, Acquisitions, and Partnerships
  • Global Antidepressants Market Analysis, Insights and Forecast, 2016-2027 
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Selective Serotonin Reuptake Inhibitors (SSRIs)
      • Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
      • Atypical Antidepressants
      • Tricyclic Antidepressants (TCAs)
      • Monoamine Oxidase Inhibitors (MAOIs)
      • Others
    • Market Analysis, Insights and Forecast – By Disorder 
      • Major Depressive Disorder
      • Obsessive Compulsive Disorder
      • Generalized Anxiety Disorder
      • Panic Disorder
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis, Insights and Forecast – By Geography
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa

ToC Continue…

Related Reports:

Antibiotics market

Antibiotics market

Antibiotics market

Antibiotics market

Antidepressants Market

Antidepressants Market

Antidepressants Market

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245


LinkedIn | Twitter | Blogs

M4.6 quake shakes areas north of Tokyo, no tsunami threat

Published by Kyodo News An earthquake with a preliminary magnitude of 4.6 struck Ibaraki Prefecture, north of Tokyo, on Thursday morning, but there was no threat of a tsunami, the weather agency said. The quake occurred at around 9:55 a.m., registering 4 on the Japanese seismic intensity scale of 7 in Bando in the prefecture,

Read More »

That Jan. 6 press conference: The Donald was wise to duck | Mulshine

Published by NJ.com Imagine if in the 2000 presidential election Al Gore had decided not to accept the results of the Electoral College and had instead encouraged a mob to “fight like hell” to prevent the votes from being counted. And imagine Gore’s supporters had broken into the Capitol intending to hang the president of

Read More »

This Simple Mindset Shift Could Help You Make Millions

Published by ValueWalk Editor’s note: Today, we’re sharing an important adaptation from Chief Analyst Stephen McBride’s recent issue of Disruption Investor… Q3 2021 hedge fund letters, conferences and more One that’s more important than any one specific stock recommendation… This is about a simple mindset shift that can make or break your retirement, so you’ll

Read More »

US denies man held in Turkey for fake passport is diplomat

Published by Al-Araby US officials denied Thursday that an American citizen arrested in Turkey for allegedly providing a fake passport to a Syrian man is a US diplomat. Turkish officials said Wednesday they detained a US diplomat at Istanbul Airport on November 11 Authorities in Turkey publicly identified the man only by his initials D.J.K.

Read More »

Dynamic Steering Response System Market Analysis From 2021 To 2028 | Global Industry Size, Share, Growth And Regional Forecast To 2028

Dynamic Steering Response System Market Analysis 2021-2028 Report provides strategists, marketers and senior management with the critical information they need to assess the global Dynamic Steering Response System market as it emerges from the Covid-19 shut down.  The impact of Coronavirus (COVID-19) on Dynamic Steering Response System has reinforced many trends already shaping the industry

Read More »